首页> 外国专利> Intralesional (Intratumoral) Dinitrochlorobenzene and Associated Compounds Coadministered with Checkpoint Inhibitors for Cancer Treatment Including Treatment of Metastatic Cutaneous Cancers

Intralesional (Intratumoral) Dinitrochlorobenzene and Associated Compounds Coadministered with Checkpoint Inhibitors for Cancer Treatment Including Treatment of Metastatic Cutaneous Cancers

机译:鼻内(瘤内)二硝基氯苯及相关化合物与检查点抑制剂共同治疗癌症,包括转移性皮肤癌的治疗

摘要

Inventor seeks patents related to the use in solid cancer patients of substances, (including, for example, dinitrohalogenated compounds) injected into tumor nodules in association with treatment with one or more checkpoint inhibitors that are administered before, during or after the intralesional (intratumoral) injection or injections.
机译:发明人寻求与在实体瘤患者中使用在肿瘤内(肿瘤内)之前,期间或之后与一种或多种检查点抑制剂治疗相关联地注射到肿瘤结节中的物质(包括(二硝基卤代化合物))相关的专利注射。

著录项

  • 公开/公告号US2018243413A1

    专利类型

  • 公开/公告日2018-08-30

    原文格式PDF

  • 申请/专利权人 MAX H. COHEN;

    申请/专利号US201715442615

  • 发明设计人 MAX H. COHEN;

    申请日2017-02-24

  • 分类号A61K39/395;A61K9;A61K31/04;A61K47/12;A61K47/44;

  • 国家 US

  • 入库时间 2022-08-21 12:58:03

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号